Marc Voigt

Marc Voigt

Chief Executive Officer at IMMUTEP LIMITED

Net worth: 240 715 $ as of 31/10/2026

53 year
Health Technology
Finance
Consumer Services

Profile

Mr. Marc Voigt is a Chairman-Supervisory Board & President at Immutep SAS, a Chief Executive Officer & Executive Director at Immutep Ltd., a Co-Managing Director at Immutep GmbH and a Member at Pharma-Lizenz-Club Deutschland.
He is on the Board of Directors at Immutep Ltd. Mr. Voigt was previously employed as a Vice Chairman-Supervisory Board by Elanix Biotechnologies AG, a MD, Chief Operating & Financial Officer by caprotec bioanalytics GmbH, a Chief Financial Officer by Revotar Biopharmaceuticals AG, a Director-Executive Board by Allianz SE, a Principal by Allianz Versicherungs AG, a Director-Finance, Legal & Business Development by Medical Enzymes AG, and a General Manager-European Operations by Immutep GmbH.
He received his MBA from Freie Universität Berlin.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
09/10/2026 14,877,345 ( 1.01% ) 240 715 $ 31/10/2026

Marc Voigt active positions

CompaniesPositionStart
IMMUTEP LIMITED Chief Executive Officer 09/07/2014
Chief Executive Officer -
Chairman 18/11/2015
Pharma-Lizenz-Club Deutschland
Corporate Officer/Principal -

Former positions of Marc Voigt

CompaniesPositionEnd
Director of Finance/CFO 02/01/2006
Director of Finance/CFO 02/01/2006
Corporate Officer/Principal -
Corporate Officer/Principal -
ALLIANZ SE Corporate Officer/Principal -
See the detail of Marc Voigt's experience

Education of Marc Voigt

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

41

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Finance

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Health Services

Health Technology

Pharma-Lizenz-Club Deutschland

Health Technology